190 related articles for article (PubMed ID: 15479806)
21. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
22. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
23. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
[TBL] [Abstract][Full Text] [Related]
24. Inappropriate activation of androgen receptor by relaxin via beta-catenin pathway.
Liu S; Vinall RL; Tepper C; Shi XB; Xue LR; Ma AH; Wang LY; Fitzgerald LD; Wu Z; Gandour-Edwards R; deVere White RW; Kung HJ
Oncogene; 2008 Jan; 27(4):499-505. PubMed ID: 17653089
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation and ubiquitination of oncogenic mutants of beta-catenin containing substitutions at Asp32.
Al-Fageeh M; Li Q; Dashwood WM; Myzak MC; Dashwood RH
Oncogene; 2004 Jun; 23(28):4839-46. PubMed ID: 15064718
[TBL] [Abstract][Full Text] [Related]
26. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
27. Trophoblast apoptosis is inhibited by hepatocyte growth factor through the Akt and beta-catenin mediated up-regulation of inducible nitric oxide synthase.
Dash PR; Whitley GS; Ayling LJ; Johnstone AP; Cartwright JE
Cell Signal; 2005 May; 17(5):571-80. PubMed ID: 15683732
[TBL] [Abstract][Full Text] [Related]
28. Implication of galectin-3 in Wnt signaling.
Shimura T; Takenaka Y; Fukumori T; Tsutsumi S; Okada K; Hogan V; Kikuchi A; Kuwano H; Raz A
Cancer Res; 2005 May; 65(9):3535-7. PubMed ID: 15867344
[TBL] [Abstract][Full Text] [Related]
29. Crossregulation of NF-kappaB by the APC/GSK-3beta/beta-catenin pathway.
Deng J; Xia W; Miller SA; Wen Y; Wang HY; Hung MC
Mol Carcinog; 2004 Mar; 39(3):139-46. PubMed ID: 14991743
[TBL] [Abstract][Full Text] [Related]
30. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
31. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
32. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
33. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
[TBL] [Abstract][Full Text] [Related]
35. Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells.
Erdal E; Ozturk N; Cagatay T; Eksioglu-Demiralp E; Ozturk M
Int J Cancer; 2005 Jul; 115(6):903-10. PubMed ID: 15723355
[TBL] [Abstract][Full Text] [Related]
36. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
Fujimuro M; Wu FY; ApRhys C; Kajumbula H; Young DB; Hayward GS; Hayward SD
Nat Med; 2003 Mar; 9(3):300-6. PubMed ID: 12592400
[TBL] [Abstract][Full Text] [Related]
37. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.
Huang L; Chen D; Liu D; Yin L; Kharbanda S; Kufe D
Cancer Res; 2005 Nov; 65(22):10413-22. PubMed ID: 16288032
[TBL] [Abstract][Full Text] [Related]
38. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
[TBL] [Abstract][Full Text] [Related]
39. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
[TBL] [Abstract][Full Text] [Related]
40. Stabilization of beta-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast.
Kemler R; Hierholzer A; Kanzler B; Kuppig S; Hansen K; Taketo MM; de Vries WN; Knowles BB; Solter D
Development; 2004 Dec; 131(23):5817-24. PubMed ID: 15525667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
